The Parkinson´s disease story
								
		
								
								
								How to understand 
								your disease of aging : ageless man  
								
								
								AGELESS MAN
										in short
										
								
										
										
								
								
								
								
								
								 AMAZON 2017-2022 AGELESS MAN  
										
										***
										
								
									Parkinson's disease (in short)
									
									Our movements are partly ordened by a 
									biochemical substance, the dopamine, 
									secreted by specialized cells from a center 
									located in brain's base (black substance, 
									also said locus niger).
									
									When those cells which secretes 
									dopamine die or are damaged, one sees 
									appearing the symptoms of Parkinson's 
									disease. 
									
									
										
											| Parkinson's 
											disease symptoms | 
										
											| Mobility 
											symptoms | Non mobility symptoms | 
										
											| shakings muscular rigidity
 slowness of movements
 balance troublesshakings
 
 | 
													
													
													
													constipationdisturbed sleep
 urgencies 
													to urinate
 | 
													  
													
													fatiguedepression
 memory 
													 
													disorders
 
													
													
													
													
													dizzynesses 
													
											 | 
									
									
									 
									
										
											| Parkinson's 
											disease treatment | 
										
											| It exists no curative 
											treatment against Parkinson's 
											disease | 
										
											| Dopamine 
											treatment   | Inhibitors mono amine oxydase 
											* 
 | Exceptional 
											treatments 
 | 
										
											| Agonists of dopamine 
 Dopamine (L.Dopa)
 |  | 
											Surgical treatment (Deep 
											cerebral stimulation) 
											Stem cells. (Research) | 
									
									
									*An inhibitor of mono amine oxydase (IMAO) 
									is a molecule which blocks the degrading 
									dopamine  enzyme.
									
									An old 
									publication going back to 1974 deserves our 
									attention. It is about a clinical study 
									evaluating the action of testosterone on  
									activity of mono amino oxydase in depressed 
									patients.
									
									Conclusion of 
									this study : Testosterone given in 
									apropriate amounts 
									lowers naturally 
									the MAO
									(Mono amino 
									oxydase) preventing the degradation of 
									dopamine (1)
									
										
											| 
											Mean
											
											
											MAO 
											activity 
											
											
											 (monoamine oxydase) 
											in
											plasma | 
										
											| 
											Before treatment | 
											
											7223 ± 3740 | 
										
											| 
											 After 
											treatment | 
											
											      
											
											1997 ± 1250 (p<0,01) | 
										
											| 
											
											400 mgrs. 
											testosterone 
											cipìonate 
											
											every 
											
											21 
											
											days | 
									
									
									Effect of a 
									treatment with testosterone on the activity 
									of the plasmatic MAO in 7 depressed men 
									(according to Klaiber and coll) (1)
									
									
									From there the
									
									interest to study the 
									daily 
									androgens' production among patients 
									presenting a Parkinson's disease with the 
									aim of substituting their missing androgens 
									in order to 
									 
									
									save their production of dopamine.
									
								1. KLAIBER E.L., BROVERMAN 
									D.M., VOGEL W., KOBAYASHI Y. The use of 
									steroid hormones in depression. in 
									Psychotropic action of hormones. Proceedings 
									of the World Cogress of biological 
									psychiatry. Buenos Aires. Argentina, 
									september 1974. Spectrum publications INC.